The agency teamed up with the software company to develop platforms and networks to collect de-identified data.
FDA and Workflow Services Detail First 100 Days of Data Collection Partnership
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours